Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756257 · ClinicalTrials.gov registry record
Blood Pressure Variability and Ischemic Stroke Outcome
A clinical trial of Acute Ischemic Stroke and Blood Pressure Variability, sponsored by Yale University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 3
- Study locations
NCT05756257 is a study of Acute Ischemic Stroke and Blood Pressure Variability that is actively recruiting participants, run by Yale University. The registered enrollment target is 150 participants, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05756257, a study of Acute Ischemic Stroke and Blood Pressure Variability, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determine a pathophysiologic mechanism of BPV's deleterious effect on functional outcome. 3. To evaluate potential treatment targets to pharmacologically reduce BPV after ischemic stroke.
Conditions Studied
Study Locations (3)
Connecticut
- Yale-New Haven Hospital - New Haven
Illinois
- University of Chicago Medical Center - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2026-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05756257
The ClinicalTrials.gov registry entry for NCT05756257 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (57% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT05756257 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05756257 about?
NCT05756257 is a clinical study titled "Blood Pressure Variability and Ischemic Stroke Outcome". The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determin...
What is the current status of trial NCT05756257?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-07-15. Estimated completion is 2026-03-30.
What conditions does trial NCT05756257 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke, Blood Pressure Variability.
Who is sponsoring clinical trial NCT05756257?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05756257 being conducted?
This trial has 3 study locations across Connecticut, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
RECRUITING · Phase 2
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
RECRUITING · Phase 3
-
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RECRUITING · Phase 2
-
SUMMIT RISE Study of Acute Ischemic Stroke Patients
RECRUITING · Phase 4
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.